Retrieved Oct 3, 2020 from Huscher, D., Thiele, K., Gromnica-Ihle, E., Hein, G., Demary, W., Dreher, R., et al
01 Improved glycemic control Tirzepatide's dual action on GIP and GLP-1 receptors, combined with cagrilintide's effects on glucose metabolism, could result in better management of blood sugar levels
Amgen's MariTide (maridebart cafraglutide) is an antibody-peptide conjugate targeting GLP-1 and GIP receptors
This remains an open question in the retatrutide research program
But as your appetite decreases and you eat less, you might need help to receive the proper nutrients
Future studies should investigate total microbial mass and metabolic pathways using biochemical analysis, proteomics, transcriptomics and genomics 40,45 and include a control group grown in anaerobiosis with these 3 antioxidant molecules